Remove 2019 Remove Clinical Practice Remove Community Remove Insurance
article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. In our prior podcast with Ira Byock on psychedelics in 2019 we talked primarily about the potential of psychedelics. Psychedelics have been used by communities around the globe for hundreds of years (or more).

article thumbnail

PC for Patients with Substance Use Disorder: Janet Ho, Sach Kale, Julie Childers

GeriPal

Substance use disorder is one of those complex issues in which clinical practice is changing rapidly. We’ve all been taught through fellowship or through clinical practice about how to assess pain. You can listen to our prior podcasts on substance use disorder here , here , here , and here. Pearls tips?